Q2 INTERIM REPORT April-June 2024
Read more
Mentice has received a 2.26 million USD order for simulation solutions from a top 20 global MedTech company
Read more

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on November 25 at 15:00 CET

Wednesday, November 20, 2019

Mentice AB (STO: MNTC) announces that the company will present its interim reports via webcast conference calls starting from the current quarter, with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

To register for the presentation of the interim report for the period January–September 2019, which will be held on November 25 at 15.00 CET, visit www.mentice.com/financial-reports-presentations

The presentation will be held in English. Participants are advised to register at least a few minutes in advance.

For further information, please contact:
Göran Malmberg, CEO, Mentice
Email: 
goran.malmberg@mentice.com

Tel US: +1 (312) 860 5610

Tel Sweden: +46 (0) 703 09 22 22

Market place: Nasdaq First North Premier, Stockholm | Ticker symbol: MNTC
Certified Adviser: FNCA Sweden AB, tel +46 8 528 00 399 e-post info@fnca.se

>20 years of innovation in medical simulation | more information at www.mentice.com
Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions.

Q2 DELÅRSRAPPORT April-Juni 2024
Läs mer
Mentice får en order på simuleringslösningar värd 2,26 miljoner USD från ett topp 20 globalt medtech bolag
Läs mer

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on November 25 at 15:00 CET

Wednesday, November 20, 2019

Mentice AB (STO: MNTC) announces that the company will present its interim reports via webcast conference calls starting from the current quarter, with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

To register for the presentation of the interim report for the period January–September 2019, which will be held on November 25 at 15.00 CET, visit www.mentice.com/financial-reports-presentations

The presentation will be held in English. Participants are advised to register at least a few minutes in advance.

For further information, please contact:
Göran Malmberg, CEO, Mentice
Email: 
goran.malmberg@mentice.com

Tel US: +1 (312) 860 5610

Tel Sweden: +46 (0) 703 09 22 22

Market place: Nasdaq First North Premier, Stockholm | Ticker symbol: MNTC
Certified Adviser: FNCA Sweden AB, tel +46 8 528 00 399 e-post info@fnca.se

>20 years of innovation in medical simulation | more information at www.mentice.com
Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions.